U.S. markets close in 6 hours 25 minutes
  • S&P 500

    3,671.06
    +2.05 (+0.06%)
     
  • Dow 30

    29,928.86
    +45.07 (+0.15%)
     
  • Nasdaq

    12,392.80
    +43.44 (+0.35%)
     
  • Russell 2000

    1,838.03
    +1.98 (+0.11%)
     
  • Crude Oil

    45.14
    -0.14 (-0.31%)
     
  • Gold

    1,844.30
    +14.10 (+0.77%)
     
  • Silver

    24.12
    +0.05 (+0.19%)
     
  • EUR/USD

    1.2152
    +0.0037 (+0.30%)
     
  • 10-Yr Bond

    0.9360
    -0.0120 (-1.27%)
     
  • GBP/USD

    1.3463
    +0.0087 (+0.65%)
     
  • USD/JPY

    103.9150
    -0.5090 (-0.49%)
     
  • BTC-USD

    19,382.66
    +433.40 (+2.29%)
     
  • CMC Crypto 200

    381.05
    +6.64 (+1.77%)
     
  • FTSE 100

    6,462.41
    -0.98 (-0.02%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Biodel's insulin drug found effective in trial

Aug 11 (Reuters) - Biodel Inc said its experimental insulin formulation was found more effective than current therapies in controlling glucose after two meals, in a mid-stage trial.

The company's shares rose about 10 percent to $2.10 before the bell.

The study was testing the drug, BIOD-531, against Eli Lilly and Co's Humalog Mix 75/25 and Humulin R U-500 in patients with type 2 diabetes with moderate insulin resistance.

(Reporting by Natalie Grover in Bangalore; Editing by Kirti Pandey)